Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series

1

The study evaluates the role of systemic treatment in patients with brain metastases treated with radiotherapy at a comprehensive cancer center.
2

A total of 676 patients with brain metastases were included, with a median follow-up of 43 months.
3

Patients were categorized based on treatment decisions made in multidisciplinary neuro-oncology board meetings.
4

Overall survival was the primary outcome measure, assessed from the diagnosis of brain metastases to death.
5

The study highlights the complexity of treatment decisions for brain metastases in the context of novel systemic therapies.

Journal Of Neuro-Oncology

by P. van Schie, B. L. T. Rijksen, M. Bot, T. Wiersma, L. G. Merckel, D. Brandsma, A. Compter, P. C. de Witt Hamer, R. Post, G. R. Borst
June 2, 2023

1